These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7738711)

  • 1. The pathology of cardiac ischaemia: cellular and molecular aspects.
    Lee JA
    J Pathol; 1995 Feb; 175(2):167-74. PubMed ID: 7738711
    [No Abstract]   [Full Text] [Related]  

  • 2. Modulation of the myocardial response to ischemia.
    Buja LM
    Lab Invest; 1998 Nov; 78(11):1345-73. PubMed ID: 9840611
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pathophysiology of myocardial ischemia].
    Baumgart D; Heusch G
    Klin Anasthesiol Intensivther; 1995; 47():3-45. PubMed ID: 7715178
    [No Abstract]   [Full Text] [Related]  

  • 4. [Protective effect of dantrolene in post-ischemic reperfusion myocardial damage].
    Balam Ortiz EO; Carvajal K; Cruz D
    Arch Inst Cardiol Mex; 1999; 69(4):311-9. PubMed ID: 10553187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial viability: evidence provided by the analysis of left ventricular systolic function.
    Lucas JR; Botvinick EH; Dae MW
    Coron Artery Dis; 1993 Jun; 4(6):485-94. PubMed ID: 8261226
    [No Abstract]   [Full Text] [Related]  

  • 6. [Myocardial reperfusion: salvation or danger for the heart muscle? Stunning, hibernation and preconditioning: the states of endogenous cardiac protection against ischemia].
    Atar D
    Schweiz Med Wochenschr; 1997 Nov; 127(48):2008-13. PubMed ID: 9490468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial stunning: an experimental act with a large clinical audience.
    Heyndrickx GR
    Arch Mal Coeur Vaiss; 2003 Jun; 96(6):665-70. PubMed ID: 12868349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Stunning, preconditioning and hibernation; aspects of ischemia and reperfusion of the myocardium].
    Ruigrok TJ
    Ned Tijdschr Geneeskd; 1993 Dec; 137(49):2526-32. PubMed ID: 8272138
    [No Abstract]   [Full Text] [Related]  

  • 9. [The biochemical and cellular bases of myocardial ischemia-reperfusion damage].
    Téllez F; Carvajal K; García C; Vásquez C; Chávez E; Moreno-Sánchez R
    Arch Inst Cardiol Mex; 1996; 66(2):162-81. PubMed ID: 8768635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model.
    du Toit EF; Genade S; Carlini S; Moolman JA; Brunner F; Lochner A
    Eur J Pharmacol; 2007 Feb; 556(1-3):115-20. PubMed ID: 17157294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attentuation of cardiac stunning by losartan in a cellular model of ischemia and reperfusion is accompanied by increased sarcoplasmic reticulum Ca2+ stores and prevention of cytosolic Ca2+ elevation.
    Louch WE; Ferrier GR; Howlett SE
    J Pharmacol Exp Ther; 2005 Jan; 312(1):238-47. PubMed ID: 15316090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic disarrangement in ischemic heart disease and its therapeutic control.
    Ferrari R
    Rev Port Cardiol; 1998 Sep; 17(9):667-84. PubMed ID: 9834638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Dose"-dependency and temporal characteristics of protection by ischaemic preconditioning against ischaemia-induced arrhythmias in rat hearts.
    Lawson CS; Coltart DJ; Hearse DJ
    J Mol Cell Cardiol; 1993 Dec; 25(12):1391-402. PubMed ID: 8158659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ischaemic heart disease: clinical improvement with metabolic approach.
    Ferrari R
    Rev Port Cardiol; 2000 Nov; 19 Suppl 5():V7-20. PubMed ID: 11206104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reperfusion injury: a review of the pathophysiology, clinical manifestations and therapeutic options.
    Maxwell SR; Lip GY
    Int J Cardiol; 1997 Jan; 58(2):95-117. PubMed ID: 9049675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular mechanisms for protecting the heart].
    Andres J
    Folia Med Cracov; 1994; 35(1-4):22-30. PubMed ID: 8586324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrastructural evidence of increased tolerance of hibernating myocardium to cardioplegic ischemia-reperfusion injury.
    Milei J; Fraga CG; Grana DR; Ferreira R; Ambrosio G
    J Am Coll Cardiol; 2004 Jun; 43(12):2329-36. PubMed ID: 15193702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitroglycerin induces late preconditioning against arrhythmias but not stunning in conscious sheep.
    Lascano EC; Valle HF; Negroni JA
    Scand Cardiovasc J; 2007 Jun; 41(3):160-6. PubMed ID: 17487765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible myocardial dysfunction in sepsis and ischemia.
    Kan H; Failinger CF; Fang Q; Finkel MS
    Crit Care Med; 2005 Dec; 33(12):2845-7. PubMed ID: 16352971
    [No Abstract]   [Full Text] [Related]  

  • 20. Ranolazine, an inhibitor of the late sodium channel current, reduces postischemic myocardial dysfunction in the rabbit.
    Hale SL; Kloner RA
    J Cardiovasc Pharmacol Ther; 2006 Dec; 11(4):249-55. PubMed ID: 17220471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.